4-76022442-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001565.4(CXCL10):āc.202A>Gā(p.Lys68Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001565.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CXCL10 | NM_001565.4 | c.202A>G | p.Lys68Glu | missense_variant | 3/4 | ENST00000306602.3 | NP_001556.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CXCL10 | ENST00000306602.3 | c.202A>G | p.Lys68Glu | missense_variant | 3/4 | 1 | NM_001565.4 | ENSP00000305651 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 248860Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135074
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1460800Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 726758
GnomAD4 genome AF: 0.000125 AC: 19AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2023 | The c.202A>G (p.K68E) alteration is located in exon 3 (coding exon 3) of the CXCL10 gene. This alteration results from a A to G substitution at nucleotide position 202, causing the lysine (K) at amino acid position 68 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at